Barriers to colorectal cancer screening: A case-control study

World Journal of Gastroenterology

Volumn 15, Issue 20, 2009, Pages 2531-2536

  Cai, Shan Rong ^a   Zhang, Su Zhan ^a   Zhu, Hong Hong ^b,c   Zheng, Shu ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b SAINT LOUIS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Barrier; Colonoscopy; Colorectal cancer screening; Community based case control study; Fecal occult blood test

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; AWARENESS; CANCER SCREENING; CHINESE; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEAR; FEMALE; FINANCIAL MANAGEMENT; GROUPS BY AGE; HEALTH CARE SYSTEM; HUMAN; INTESTINE PREPARATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; OCCULT BLOOD; PAIN; POPULATION BASED CASE CONTROL STUDY; QUESTIONNAIRE; SCREENING TEST; SEX DIFFERENCE; URBAN AREA; AGED; ATTITUDE TO HEALTH; CANCER DIAGNOSIS; CASE CONTROL STUDY; COLORECTAL TUMOR; ECONOMICS; HEALTH EDUCATION; MIDDLE AGED; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT;

ADULT; AGED; ATTITUDE TO HEALTH; CASE-CONTROL STUDIES; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEALTH EDUCATION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT EDUCATION AS TOPIC;

EID: 67650169924     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.15.2531     Document Type: Article

References (25)

1. Yang L, Parkin DM, Li LD, Chen YD, Bray F. Estimation and projection of the national profile of cancer mortality in China: 1991-2005. Br J Cancer 2004; 90: 2157-2166
2. Dong ZW, Qiao YL, Li LD, Chen YD, Wang RT, Lei TH, Rao KQ, Wang RK, Zhao P, You WC, Lu FZ, Dai XD, Wang GQ, Luo XM, Zhou HC. Report of Chinese cancer control strategy. Zhongguo Zhongliu 2002; 11: 250-260
3. Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993; 328: 1365-1371
4. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-437
5. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-1477
6. Jørgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002; 50: 29-32
7. Zheng S, Chen K, Liu X, Ma X, Yu H, Chen K, Yao K, Zhou L, Wang L, Qiu P, Deng Y, Zhang S. Cluster randomization trial of sequence mass screening for colorectal cancer. Dis Colon Rectum 2003; 46: 51-58
8. Coombs A, Jones-McLean E, Le-Petit C, Flanagan W, White K, Berthelot J-M, Villeneuve P. Technical Report for the National Committee on Colorectal Cancer Screening. Ottawa: Health Canada, Statistics Canada, 2002
9. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst 1997; 89: 1406-1422
10. Olynyk JK, Aquilia S, Fletcher DR, Dickinson JA. Flexible sigmoidoscopy screening for colorectal cancer in average-risk subjects: a community-based pilot project. Med J Aust 1996; 165: 74-76
11. Senore C, Segnan N, Rossini FP, Ferraris R, Cavallero M, Coppola F, Pennazio M, Atkin WS. Screening for colorectal cancer by once only sigmoidoscopy: a feasibility study in Turin, Italy. J Med Screen 1996; 3: 72-78
12. Thompson RS, Michnich ME, Gray J, Friedlander L, Gilson B. Maximizing compliance with hemoccult screening for colon cancer in clinical practice. Med Care 1986; 24: 904-914
13. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002; 359: 1291-1300
14. Federici A, Giorgi Rossi P, Bartolozzi F, Farchi S, Borgia P, Guastcchi G. The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy). Cancer Causes Control 2006; 17: 45-52
15. Cai SR, Zhang SZ, Zhou L, Zheng S. Population-based colorectal cancer screening in Hangzhou city. Shiyong Zhongliuxue Zazhi 2006; 21: 177-178
16. Giorgi Rossi P, Federici A, Bartolozzi F, Farchi S, Borgia P, Guasticchi G. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072]. BMC Public Health 2005; 5: 139
17. Wong NY, Nenny S, Guy RJ, Seow-Choen F. Adults in a high-risk area are unaware of the importance of colorectal cancer: a telephone and mail survey. Dis Colon Rectum 2002; 45: 946-950; quiz 951-954
18. Ng ES, Tan CH, Teo DC, Seah CY, Phua KH. Knowledge and perceptions regarding colorectal cancer screening among Chinese - a community-based survey in Singapore. Prev Med 2007; 45: 332-335
19. Winawer S, Faivre J, Selby J, Bertaro L, Chen TH, Kroborg O, Levin B, Mandel J, O'Morain C, Richards M, Rennert G, Russo A, Saito H, Semigfnovsky B, Wong B, Smith R. Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol 2005; 16: 31-33
20. Liao CC, Wang HY, Lin RS, Hsieh CY, Sung FC. Addressing Taiwan's high incidence of cervical cancer: factors associated with the Nation's low compliance with Papanicolaou screening in Taiwan. Public Health 2006; 120: 1170-1176
21. Federici A, Marinacci C, Mangia M, Borgia P, Giorgi Rossi P, Guasticchi G. Is the type of test used for mass colorectal cancer screening a determinant of compliance? A cluster-randomized controlled trial comparing fecal occult blood testing with flexible sigmoidoscopy. Cancer Detect Prev 2006; 30: 347-353
22. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001; 93: 1704-1713
23. Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2005. CA Cancer J Clin 2005; 55: 31-44; quiz 55-56
24. Andrykowski MA, Zhang M, Pavlik EJ, Kryscio RJ. Factors associated with return for routine annual screening in an ovarian cancer screening program. Gynecol Oncol 2007; 104: 695-701
25. Baré ML, Montes J, Florensa R, Sentís M, Donoso L. Factors related to non-participation in a population-based breast cancer screening programme. Eur J Cancer Prev 2003; 12: 487-494